Bleeding at Gastric Cancer Clinical Trial
Gastrointestinal(GI) hemorrhage related with gastric cancer is prevalent in advanced cases
mostly. As endoscopic hemostatic methods such as argon plasma ablation (APC) had developed,
controlling GI hemorrhage in gastric cancer is much easier these days. but re-bleeding rate
is still high, even after successful hemostasis with APC or electrical coagulation.
Furthermore patients who were experienced re-bleeding are expected poorer survival outcomes
than those who are not. So excellent bleeding control in gastric cancer is most important in
GI hemorrhage of gastric cancer.
Recently developed hemostatic powder [Endo-Clot(TM)] is easy to use and have proven its
usefulness in GI hemorrhage in peptic ulcer diseases. So in this study, investigator will
try to find out feasibility & safety of Endo-Clot(TM) in GI hemorrhage in gastric cancer.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment